Literature DB >> 8095146

Predictors of rapid progression to AIDS in HIV-1 seroconverters.

I P Keet1, P Krijnen, M Koot, J M Lange, F Miedema, J Goudsmit, R A Coutinho.   

Abstract

OBJECTIVE: To determine whether at the time of HIV-1 seroconversion rapid progressors to AIDS and a low CD4+ count can be distinguished by the clinical presentation of primary HIV-1 infection and serological and immunological characteristics.
DESIGN: Prospective cohort study on HIV-1 infection in homosexual men.
SETTING: The Municipal Health Service, Amsterdam, The Netherlands.
SUBJECTS: One hundred and eight men who seroconverted for HIV-1 during follow-up. MAIN OUTCOME MEASURES: Progression to AIDS and progression to a CD4+ lymphocyte count < 200 x 10(6)/l.
RESULTS: Symptomatic primary HIV infection with fever and skin rash, absence of anti-HIV core and transient HIV p24 antigenemia were independent predictors of progression to AIDS at the time of HIV-1 seroconversion. A low CD4+ count immediately after seroconversion and the calendar year were independent predictors of progression to a low CD4+ count at the time of HIV-1 seroconversion.
CONCLUSIONS: Even in the earliest stage of HIV-1 infection a small group of individuals at high risk for rapid progression to AIDS can be recognized by the clinical presentation of primary HIV infection, the presence of HIV p24 antigenaemia and the absence of a serological response to HIV core protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095146     DOI: 10.1097/00002030-199301000-00008

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  40 in total

1.  Primary HIV.

Authors:  J Fox; J Weber; S Fidler
Journal:  Sex Transm Infect       Date:  2006-08       Impact factor: 3.519

2.  Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS.

Authors:  E L Delwart; H Pan; H W Sheppard; D Wolpert; A U Neumann; B Korber; J I Mullins
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  HIV-1 Transmission, Replication Fitness and Disease Progression.

Authors:  Tasha Biesinger; Jason T Kimata
Journal:  Virology (Auckl)       Date:  2008-07-14

4.  Rapid evolution of human immunodeficiency virus strains with increased replicative capacity during the seronegative window of primary infection.

Authors:  J Ferbas; E S Daar; K Grovit-Ferbas; W J Lech; R Detels; J V Giorgi; A H Kaplan
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

5.  Evolution of human immunodeficiency virus type 1 env sequence variation in patients with diverse rates of disease progression and T-cell function.

Authors:  R A McDonald; D L Mayers; R C Chung; K F Wagner; S Ratto-Kim; D L Birx; N L Michael
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

6.  The UK register of HIV seroconverters: methods and analytical issues. UK register of HIV seroconverters (UKRHS) Steering Committee.

Authors: 
Journal:  Epidemiol Infect       Date:  1996-10       Impact factor: 2.451

7.  Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission.

Authors:  A B van't Wout; N A Kootstra; G A Mulder-Kampinga; N Albrecht-van Lent; H J Scherpbier; J Veenstra; K Boer; R A Coutinho; F Miedema; H Schuitemaker
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

8.  Functional characterization of human immunodeficiency virus type 1 nef genes in patients with divergent rates of disease progression.

Authors:  N L Michael; G Chang; L A d'Arcy; C J Tseng; D L Birx; H W Sheppard
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Early stages of simian immunodeficiency virus infection in lymph nodes. Evidence for high viral load and successive populations of target cells.

Authors:  L Chakrabarti; P Isola; M C Cumont; M A Claessens-Maire; M Hurtrel; L Montagnier; B Hurtrel
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

10.  In vitro anti-HIV-1 antibody production in subjects in different stages of HIV-1 infection.

Authors:  S Rusconi; A Riva; L Meroni; G Zehender; F Cocchi; L Scapellato; M Galli
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.